At the Cancer Prevention at Work (CPW) project we are assessing the efficacy and cost-effectiveness of incorporating Helicobacter pylori (Hp), Hepatitis C virus (HCV), and Human Papillomavirus (HPV) prevention protocols into ongoing primary occupational surveillance programs in Europe. For achieving this mission, we will engage with local and regional-level stakeholders, including health authorities, companies, workers, and communities, among others. We are a research and innovation project funded by the European Union's Horizon Europe program under the grant agreement nº 101104716. Project coordinator:
· Alma mater studiorum - Università di Bologna, Italy
Project partners:
· National Institute of Public Health, Romania
· Romanian Society for Occupational Medicine, Romania
· Clinic Hospital Colentina, Bucharest, Romania
· Timisoara Municipal Emergency Clinical Hospital, Romania
· Regional Authority of Public Health Banská Bystrica, Slovakia
· University of Southern Denmark, Denmark
· WEDO | Project Intelligence Made Easy SL, Spain
· F.D. Roosevelt University General Hospital of Banská Bystrica, Slovakia
· Fundacion para la investigacion y la innovacion biosanitaria del Principado de Asturias, Spain
· Intesa Sanpaolo SPA, Italy
· University of Turin, Italy
· FLAT srl, Italy
· University Hospital Heidelberg, Germany
· RPA Europe Prague s.r.o., Czech Republic
· Regione Emilia Romagna, Italy
· Zeleziarne Podbrezova a.s., Slovakia
· Health Service of the Principality of Asturias (SESPA), Spain
· Local Health Authority "City of Turin", Italy
---
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.